1. Home
  2. EFSI vs CCCC Comparison

EFSI vs CCCC Comparison

Compare EFSI & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Financial Services Inc

EFSI

Eagle Financial Services Inc

HOLD

Current Price

$40.05

Market Cap

214.3M

Sector

Finance

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.03

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFSI
CCCC
Founded
1881
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
214.3M
240.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
EFSI
CCCC
Price
$40.05
$2.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$39.50
$7.25
AVG Volume (30 Days)
15.1K
1.5M
Earning Date
10-23-2025
11-06-2025
Dividend Yield
3.09%
N/A
EPS Growth
N/A
N/A
EPS
2.13
N/A
Revenue
$66,122,000.00
$30,108,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$27.28
N/A
P/E Ratio
$18.83
N/A
Revenue Growth
3.18
N/A
52 Week Low
$28.70
$1.09
52 Week High
$40.71
$4.44

Technical Indicators

Market Signals
Indicator
EFSI
CCCC
Relative Strength Index (RSI) 77.71 34.55
Support Level $39.51 $2.50
Resistance Level $40.71 $2.69
Average True Range (ATR) 0.78 0.19
MACD 0.25 -0.07
Stochastic Oscillator 98.36 5.92

Price Performance

Historical Comparison
EFSI
CCCC

About EFSI Eagle Financial Services Inc

Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: